Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Wright

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Infection Prevention|October 10, 2017
Central venous catheter dressing durability: an evaluationAnnette Richardson, Andrew Melling, Chris Straughan, et al.
Clinical Immunology (Orlando, Fla.)|September 19, 2009
Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survivalMark J Dobrzanski, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
International Journal of Molecular Medicine|March 14, 2002
Adoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cellsStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Veterinary Research|April 28, 2012
Maternal and foetal immune responses of cattle following an experimental challenge with Neospora caninum at day 70 of gestationPaul M Bartley, Stephen E Wright, Stephen W Maley, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2011
Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancerMark J Dobrzanski, Kathleen A Rewers-Felkins, Khaliquzzaman A Samad, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Opportunities and challenges of clustering, crossing over, and using registry data in the PEPTIC trialPaul J Young, Sean M Bagshaw, Andrew B Forbes, et al.
Critical Care Medicine|May 23, 2008
Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasmaStephen E Wright, Christopher P Snowden, Sally C Athey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2021
Phosphoinositide 3-Kinase δ Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of InfectionJonathan Scott, Marie-Hélène Ruchaud-Sparagano, Kathryn Musgrave, et al.
South Asian Journal of Cancer|December 31, 2025
The Effect of Perioperative Cimetidine on the Outcomes of Stage 2 MelanomaFalah Abu Hassan, Mohanad Al Obaidi, Yasir Al-Hilli, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Infection Prevention|October 10, 2017
Central venous catheter dressing durability: an evaluationAnnette Richardson, Andrew Melling, Chris Straughan, et al.
Clinical Immunology (Orlando, Fla.)|September 19, 2009
Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survivalMark J Dobrzanski, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
International Journal of Molecular Medicine|March 14, 2002
Adoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cellsStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Veterinary Research|April 28, 2012
Maternal and foetal immune responses of cattle following an experimental challenge with Neospora caninum at day 70 of gestationPaul M Bartley, Stephen E Wright, Stephen W Maley, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2011
Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancerMark J Dobrzanski, Kathleen A Rewers-Felkins, Khaliquzzaman A Samad, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Opportunities and challenges of clustering, crossing over, and using registry data in the PEPTIC trialPaul J Young, Sean M Bagshaw, Andrew B Forbes, et al.
Critical Care Medicine|May 23, 2008
Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasmaStephen E Wright, Christopher P Snowden, Sally C Athey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2021
Phosphoinositide 3-Kinase δ Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of InfectionJonathan Scott, Marie-Hélène Ruchaud-Sparagano, Kathryn Musgrave, et al.
South Asian Journal of Cancer|December 31, 2025
The Effect of Perioperative Cimetidine on the Outcomes of Stage 2 MelanomaFalah Abu Hassan, Mohanad Al Obaidi, Yasir Al-Hilli, et al.
Pageof 6